Lactamase Harboring the M169L Clinical Mutation

Lactamase Harboring the M169L Clinical Mutation

The Journal of Antibiotics (2016) 69, 858–862 & 2016 Japan Antibiotics Research Association All rights reserved 0021-8820/16 www.nature.com/ja ORIGINAL ARTICLE Kinetic characterization of GES-22 β-lactamase harboring the M169L clinical mutation Aysegul Saral1,2, David A Leonard3, Azer Ozad Duzgun4, Aysegul Copur Cicek5, Cynthia M June3 and Cemal Sandalli2 The class A β-lactamase GES-22 has been identified in Acinetobacter baumannii isolates in Turkey, and subsequently shown to differ from GES-11 by a single substitution (M169L). Because M169 is part of the omega loop, a structure that is known to have major effects on substrate selectivity in class A β-lactamases, we expressed, purified and kinetically characterized this novel variant. Our results show that compared with GES-116×His, GES-226×His displays more efficient hydrolysis of penicillins, and aztreonam, but a loss of efficiency against ceftazidime. In addition, the M169L substitution confers on GES-22 more efficient hydrolysis of the mechanistic inhibitors clavulanic acid and sulbactam. These effects are highly similar to other mutations at the homologous position in other class A β-lactamases, suggesting that this methionine has a key structural role in aligning active site residues and in substrate selectivity across the class. The Journal of Antibiotics (2016) 69, 858–862; doi:10.1038/ja.2016.48; published online 11 May 2016 INTRODUCTION The origin of GES-type β-lactamases remains unknown, but β-Lactamases are bacterial enzymes that hydrolyze β-lactam they generally are found in class 1 integron gene cassettes on both antibiotics, rendering these compounds ineffective.1 These enzymes chromosomes and plasmids.7 The first GES β-lactamase, GES-1, are grouped into four classes A, B, C and D, with class A, C and D was described in France in 2000.8 This enzyme confers resistance enzymes making use of a catalytic serine to hydrolyze the β-lactam to penicillins, narrow- and expanded-spectrum cephalosporins ring, and class B enzymes using a metal cofactor (Zn). Penicillins and and ceftazidime,9 and 26 variants have been reported to date cephalosporins have been used to treat bacterial infections, but their (http://lahey.org/studies/other.asp). GES-2 showed better hydrolytic efficacy has been greatly diminished by resistance mechanisms. efficiency against imipenem than GES-1, and its activity was less When these antibiotics began to be inactivated by class A β-lactamases, inhibited by clavulanic acid, tazobactam and imipenem than GES-1. several generations of cephalosporins were developed for use in There is a single amino acid change between GES-1 and GES-2 clinical settings. Inappropriate use of these drugs resulted in the (G170N) at position 170 in the omega loop of Ambler class A extended-spectrum β-lactamases (ESBL).2 ESBLs confer resistance to enzymes.8 GES-3 has two amino acid substitutions compared with penicillins, first-, second- and third-generation cephalosporins, and GES-1 (E104K, M62T).10 Substitution at the G243 residue in GES-9 aztreonam (but not the cephamycins or carbapenems) and they are and GES-11 confers increased activity against aztreonam and inhibited by β-lactamase inhibitors. ESBL type β-lactamases are found ceftazidime.9 GES-4, -5, -6 and -14 possess a substitution at the most commonly in class A, though there are a growing number of G170 residue (N or S) that leads to carbapenemase activity.11 GES-12 examples in class C and D.3 Most class A ESBLs are found in the TEM, differs from GES-11 by a single amino acid (T237A), which causes SHV and CTX-M families,1 though variants in PER, VEB, TLA-1, twofold higher efficiency against aztreonam and ceftazidime. GES-14, GES/IBC, SFO-1 and BES-1 have also been reported.4 with two amino acid substitutions (G243A and G170S), can hydrolyze Acinetobacter baumannii is a Gram-negative, opportunistic pathogen both oxyimino-cephalosporins and carbapenems.9 that causes a range of infections, including bacteraemia, pneumonia, GES-type β-lactamases have been found in Pseudomonas aeruginosa, meningitis, urinary tract infections and wound infections.5 ESBLs Escherichia coli, Klebsiella pneumoniae, Aeromonas media, Aeromonas from the Ambler class A group including VEB-1, PER-1, PER-2, veronii, Klebsiella oxytoca, A. baumannii, Serratia marcescens and TEM-92, TEM-116, CTXM-2, CTX-M-43, GES-11, -12, -14, -22 and Enterobacter cloacae. More recently, GES-22 was found in an -24 have been found in A. baumannii.6 A. baumannii isolate from Turkey.12 GES-22 differs from GES-11 by 1Department of Nutrition and Dietetics, Faculty of Health Sciences, Artvin Coruh University, Artvin, Turkey; 2Microbiology and Molecular Biology Research Laboratory, Department of Biology, Faculty of Arts and Sciences, Recep Tayyip Erdogan University, Rize, Turkey; 3Department of Chemistry, Grand Valley State University, Allendale, MI, USA; 4Department of Genetics and Bioengineering, Faculty of Engineering and Natural Sciences, Gümüşhane University, Gumushane, Turkey and 5Department of Medical Microbiology, Faculty of Medicine, Recep Tayyip Erdogan University, Rize, Turkey Correspondence: Dr C Sandalli, Microbiology and Molecular Biology Research Laboratory, Department of Biology, Faculty of Arts and Sciences, Recep Tayyip Erdogan University, Rize 53100, Turkey. E-mail: [email protected] Received 13 December 2015; revised 16 March 2016; accepted 30 March 2016; published online 11 May 2016 GES-22 β-lactamase in M169L clinical mutation ASaralet al 859 one amino acid substitution M169L, the only known variant at this peptides of GES-22 and GES-11 were determined using SignalP 4.1 server position. GES-22 and its parent GES-11 have been reported in (http://www.cbs.dtu.dk/services/SignalP/). The DNA sequences of GES-11 and previous studies from Turkey.5,13 In another study from Kuwait, GES-22 without the signal sequence (that is, the first 18 residues) were fi GES-type ESBLs were found in A. baumannii.14 Altogether, these ampli ed using iProof High-Fidelity DNA Polymerase (Bio-Rad, Hercules, CA, ′ studies show that the Middle East and Turkey could be a reservoir for USA) and primers with restriction sites for EcoRI and XhoI(GES_EcoRI_F:5- GAATTCTCGGAAAAATTAACCTTCAAGACC-3′ and GES _XhoI_R: 5′- A. baumannii producing GES-type ESBLs.5 Sequencing of the integron CTCGAGCTATTTGTCCGTGCTCAGGATGA-3′). After restriction, the PCR carrying bla and bla in isolates from Turkey show that GES-11 GES-22 amplicons were introduced into pET28a with T4 DNA ligase. Sequencing of the they possess the same genetic structure as GES-11 from France. coding regions was carried out by Macrogen, Seoul, Korea. Sequencing results This suggests that GES-22 evolved from GES-11 under conditions of were analyzed using the alignment search tool BLAST (http://www.ncbi.nlm. 12 antibiotic stress with one amino acid change. nih.gov/BLAST) and the multiple sequence alignment program CLUSTALW Position 169 is located in the omega loop of class A β-lactamases (http:// www.ebi.ac.uk/Tools/msa/clustalw2/). including members of the GES-type β-lactamases (Figure 1). In a previous study of the SHV β-lactamase subfamily, it was shown that Expression and purification of GES-22 and GES-11 the substitution R169L in SHV-57 induced a conformational change pET28a-GES-22 and pET28a-GES-11 were transformed into E. coli BL21 (DE3) in N170. This mutation that causes resistance to ceftazidime, but not for overexpression. E. coli cells harboring pET28a-GES-22 and pET28a-GES-11 to cefazolin is inhibited with clavulanic acid.15 Also, increased vector were grown to an OD at 600 nm of ~ 0.6 in LB medium containing ceftazidime hydrolysis caused by mutations at position 169 have been kanamycin (25 μgml− 1) at 37 °C, and overexpression was induced by the – described in other studies.16 18 Position 169 is most typically addition of 0.1 mM isopropyl β-D-thiogalactopyranoside overnight at 18 °C. occupied by methionine or leucine in class A β-lactamases, though The cells were collected by centrifugation and lysed by sonication. some exceptions exist (TLA-2, SHV-57, CTX-M-93; Figure 2). The After sonication, the lysate was centrifuged at 15 000 r.p.m. in a Sorvall fi neighboring residue at position 170 is important in imipenem SS-34 rotor (Sorvall, Newtown, CT, USA) for 30 min at 4 °C. The clari ed supernatants were loaded onto a HisPur Cobalt Resin (Thermo Fisher hydrolysis in GES-type β-lactamases.11,19 The residue at position 170 Scientific, Rockford, IL, USA) equilibrated with 50 mM Tris-HCl, 0.5 M NaCl, affects the conformation of the active site of the GES-type β-lactamases 10 mM imidazole, pH 7.4. The column was then washed extensively with through interactions with the E166 side chain. The presence of a column equilibration buffer, and then washed with 50 mM Tris-HCl, 0.5 M hydrogen-bonding interaction between S170 and E166 has been NaCl, 25 mM imidazole, pH 7.4. The purified β-lactamase protein was eluted 19 found to be vitally important for carbapenemase activity. with 50 mM Tris-HCl, 0.5 M NaCl, 250 mM imidazole, pH 7.4. The GES-22 and Given the importance of M169 and other proximal residues, we GES-11 containing fractions were pooled and dialyzed against 50 mM Tris-HCl, wished to determine whether position 169 in GES-22 altered 0.2 M NaCl, pH 7.4 overnight. The protein concentrations were determined by the activity of this β-lactamase against pencillins, cephalosporins measuring absorbance at 280 nm, and its purity was shown to be 495% by and carbapenems. Toward this aim, we purified the enzyme and used SDS-PAGE. Protein samples were stored at − 80 °C. steady-state kinetic analysis to measure its activity against a wide variety of these substrates.

View Full Text

Details

  • File Type
    pdf
  • Upload Time
    -
  • Content Languages
    English
  • Upload User
    Anonymous/Not logged-in
  • File Pages
    5 Page
  • File Size
    -

Download

Channel Download Status
Express Download Enable

Copyright

We respect the copyrights and intellectual property rights of all users. All uploaded documents are either original works of the uploader or authorized works of the rightful owners.

  • Not to be reproduced or distributed without explicit permission.
  • Not used for commercial purposes outside of approved use cases.
  • Not used to infringe on the rights of the original creators.
  • If you believe any content infringes your copyright, please contact us immediately.

Support

For help with questions, suggestions, or problems, please contact us